OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Share Price

Certificat

DE000GG10356

Real-time BOERSE MUENCHEN 03:56:26 20/06/2024 pm IST
5.28 EUR +0.57% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month+22.66%
1 month+38.89%
Date Price Change
20/24/20 5.28 +0.57%
19/24/19 5.25 +5.21%
18/24/18 4.99 +5.27%
17/24/17 4.74 +2.60%
14/24/14 4.62 +0.65%

Real-time BOERSE MUENCHEN

Last update June 20, 2024 at 03:56 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GG1035
ISINDE000GG10356
Date issued 12/12/2023
Strike 294.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.75
Lowest since issue 0.91
Spread 0.07
Spread %1.33%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus